The role of AMPK/mTOR signaling pathway in anticancer activity of metformin
- PMID: 34062070
- PMCID: PMC8820546
- DOI: 10.33549/physiolres.934618
The role of AMPK/mTOR signaling pathway in anticancer activity of metformin
Abstract
Metformin (MTF) is a widely used drug for the treatment of diabetes mellitus type 2 (DM2) and frequently used as an adjuvant therapy for polycystic ovarian syndrome, metabolic syndrome, and in some cases also tuberculosis. Its protective effect on the cardiovascular system has also been described. Recently, MTF was subjected to various analyzes and studies that showed its beneficial effects in cancer treatment such as reducing cancer cell proliferation, reducing tumor growth, inducing apoptosis, reducing cancer risk in diabetic patients, or reducing likelihood of relapse. One of the MTF's mechanisms of action is the activation of adenosine-monophosphate-activated protein kinase (AMPK). Several studies have shown that AMPK/mammalian target of rapamycin (mTOR) pathway has anticancer effect in vivo and in vitro. The aim of this review is to present the anticancer activity of MTF highlighting the importance of the AMPK/mTOR pathway in the cancer process.
Conflict of interest statement
There is no conflict of interest.
Figures


Similar articles
-
Metformin's anticancer odyssey: Revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review.Biochimie. 2025 Jun;233:109-121. doi: 10.1016/j.biochi.2025.03.002. Epub 2025 Mar 8. Biochimie. 2025. PMID: 40058683 Review.
-
Mechanism and application of metformin in kidney diseases: An update.Biomed Pharmacother. 2021 Jun;138:111454. doi: 10.1016/j.biopha.2021.111454. Epub 2021 Mar 11. Biomed Pharmacother. 2021. PMID: 33714781 Review.
-
Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.Int J Oncol. 2019 Apr;54(4):1271-1281. doi: 10.3892/ijo.2019.4704. Epub 2019 Jan 30. Int J Oncol. 2019. PMID: 30720062 Free PMC article.
-
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways.Cell Biochem Funct. 2024 Jun;42(4):e4071. doi: 10.1002/cbf.4071. Cell Biochem Funct. 2024. PMID: 38863255 Review.
-
Metformin and cancer.Rev Diabet Stud. 2013 Winter;10(4):228-35. doi: 10.1900/RDS.2013.10.228. Epub 2014 Feb 10. Rev Diabet Stud. 2013. PMID: 24841876 Free PMC article. Review.
Cited by
-
Caffeic Acid and Diseases-Mechanisms of Action.Int J Mol Sci. 2022 Dec 29;24(1):588. doi: 10.3390/ijms24010588. Int J Mol Sci. 2022. PMID: 36614030 Free PMC article. Review.
-
The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge.Int J Mol Sci. 2024 Dec 24;26(1):37. doi: 10.3390/ijms26010037. Int J Mol Sci. 2024. PMID: 39795891 Free PMC article.
-
Drug Repurposing of New Treatments for Neuroendocrine Tumors.Cancers (Basel). 2025 Jul 28;17(15):2488. doi: 10.3390/cancers17152488. Cancers (Basel). 2025. PMID: 40805187 Free PMC article. Review.
-
Metformin Prevents Tumor Cell Growth and Invasion of Human Hormone Receptor-Positive Breast Cancer (HR+ BC) Cells via FOXA1 Inhibition.Int J Mol Sci. 2024 Jul 8;25(13):7494. doi: 10.3390/ijms25137494. Int J Mol Sci. 2024. PMID: 39000600 Free PMC article.
-
PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.Physiol Res. 2022 Dec 27;71(Suppl 1):S125-S135. doi: 10.33549/physiolres.935030. Physiol Res. 2022. PMID: 36592448 Free PMC article.
References
-
- CANTORIA MJ, PATEL H, BOROS LG, MEUILLET EJ. Pancreatic cancer-insights into molecular mechanisms and novel approaches to early detection and treatment. London, UK: IntechOpen; 2014. Metformin and pancreatic cancer metabolism. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous